These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 33221809

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success.
    Laiginhas R, Silva MI, Rosas V, Penas S, Fernandes VA, Rocha-Sousa A, Carneiro Â, Falcão-Reis F, Falcão MS.
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):83-89. PubMed ID: 29082448
    [Abstract] [Full Text] [Related]

  • 44. Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomes.
    Lukic M, Williams G, Shalchi Z, Patel PJ, Hykin PG, Hamilton RD, Rajendram R.
    Eur J Ophthalmol; 2021 May; 31(3):1201-1207. PubMed ID: 32429690
    [Abstract] [Full Text] [Related]

  • 45. Quantitative analysis of external limiting membrane, ellipsoid zone and interdigitation zone defects in patients with macular holes.
    Houly JR, Veloso CE, Passos E, Nehemy MB.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1297-1306. PubMed ID: 28412772
    [Abstract] [Full Text] [Related]

  • 46. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y, Güler E, Gürağaç FB.
    Curr Eye Res; 2016 Jul; 41(1):107-13. PubMed ID: 25610946
    [Abstract] [Full Text] [Related]

  • 47. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y, Li L, Xu G, Wang W.
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
    Lee HY, Lee SY, Park JS.
    Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
    [Abstract] [Full Text] [Related]

  • 50. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Sep; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 51. Changes in foveal photoreceptor integrity after idiopathic epiretinal membrane surgery and its relationship with visual outcomes.
    Yang X, Yu Y, Wu X, Zhang K, Qi B, Wang X, Liu W.
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):925-933. PubMed ID: 36326950
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
    Arevalo JF, Sanchez JG, Fromow-Guerra J, Wu L, Berrocal MH, Farah ME, Cardillo J, Rodríguez FJ, Pan-American Collaborative Retina Study Group (PACORES).
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118
    [Abstract] [Full Text] [Related]

  • 55. The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema.
    Sonmez K, Tezel TH, Kaplan HJ.
    Int Ophthalmol; 2013 Feb; 33(1):15-25. PubMed ID: 22890369
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
    Fonollosa A, Zarranz-Ventura J, Valverde A, Becerra E, Bernal-Morales C, Pastor-Idoate S, Zapata MA.
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA, Diab MM, Abo-Elenin M.
    Retina; 2010 Nov; 30(10):1638-45. PubMed ID: 20838357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.